Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: A retrospective study in 314 cases

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 93, Issue 1, 2000, Pages 71-75

  Infantolino, Chiara ^a   Fabris, Paolo ^b   Infantolino, Domenico ^c   Biasin, Maria Raffaella ^c   Venza, Enzo ^c   Tositti, Giulia ^b   Minucci, Daria ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c Cardiac Surgery Division   (Italy)

Author keywords

Cervical cancer; Cervical screening; HPV genotypes; Human Papillomavirus (HPV); Pap test

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

EID: 0033795873     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00299-7     Document Type: Article

References (20)

1. Koss L.G. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. J Am Med Assoc. 261:1989;737-743.
2. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. J Am Med Assoc. 262:1989;931-934.
3. Davey D.D., Naryshkin S., Nielsen M.L., Kline T.S. Atypical squamous cells of undetermined significance, interlaboratory comparison and quality assurance monitors. Diagn Cytopathol. 11:1994;390-396.
4. Bosh F.X., Manos M.M., Muñoz N., et al. Prevalence of human papillomavirus in cervical cancer: a world-wide perspective. J Natl Cancer Inst. 87:1995;796-802.
5. Shiffman Brinton L.A. The epidemiology of cervical carcinogenesis. Cancer. 76:1995;1888-1991.
6. Ngeangel C., Muñoz N., Bosh X.F., et al. The causes of cervical cancer in the Philippines: a case control study. J Natl Cancer Inst. 90:1998;43-49.
7. Zur Hausen H. Papillomavirus in human cancer. Molec. Cancerog. 1:1988;175-182.
8. Reeves W.C., Bringhton L.A., Garcia M., et al. Human papillomavirus (HPV) infection and cervical cancer in Latin America. New Engl J Med. 320:1989;1437-1441.
9. Lungu O., Sun X.W., Felix J., et al. Human papilloma virus (HPV) infection type to grade of cervical intraepithelial neoplasia. J Am Med Assoc. 267:1992;2493-2496.
10. Schiffman M.H., Bauer H.M., Hoover R.N. Epidemiologic evidence showing that human papilloma virus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 85:1993;958-964.
11. Kiviat N.B., Koutsky L.A., Critchlow C.W., et al. Prevalence and cytologic manifestation of human papillomavirus (HPV) type 6, 11, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52 and 56 among 500 consecutive women. Int J Gynecol Pathol. 11:1992;197-203.
12. Nobbenhuis M.A.E., Wallboomers J.M.M., Helmerhorst T.J.M., Rozendaal L., et al. Relation of human papillomavirus status to cervical lesions consequences for cervical-cancer screening: a prospective study. Lancet. 354:1999;20-25.
13. Kaufman H.R., Adam E. Is human papillomavirus testing of value in clinical practice? Am J Obstet Gynecol. 180:1999;1049-1053.
14. Adam E., Kaufman H.R., Berkova Z., Icenogle J., Reeves W.C. Is human papillomavirus testing an effective triage method for detection of high grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol. 178:1998;1235-1244.
15. Bollen L.J.M., Tjoong-A-Hung S.P., Van der Velden J., et al. Human papillomavirus deoxyribonucleic acid detection in mildly or moderately displastic smears: a possible method for selection patients for colposcopy. Am J Obstet Gynecol. 177:1997;548-553.
16. Reid R., Lorincz A.T. Human papillomavirus tests. Baillieres Clin Obster Gynecol. 9:1995;65-103.
17. Kaufman H.R., Adam E., Icenogle J., Reeves W.C. Human papillomavirus testing as a triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions; sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol. 177:1997;930-966.
18. Cristopher P.C. Detecting very genital papilloma virus infection what does it mean? Am J Path. 153:1998;1667-1670.
19. Cuzick J., Szarewski A., Terry G., et al. Human papilloma virus testing in primary cervical screening. Lancet. 345:1995;1533-1536.
20. Manos M.M., Kinney W.K., Hurley L.B., et al. Identifying women with cervical neoplasia using human papilloma DNA testing for equivocal Papanicolaou results. J Am Med Assoc. 281:1999;1605-1610.